A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma

Shoushtari, A. N., Khan, S., Komatsubara, K., Feun, L., Acquavella, N., Singh-Kandah, S., Negri, T., Nesson, A., Abbate, K., Cremers, S., Musi, E., Ambrosini, G., Lee, S., Schwartz, G. K., & Carvajal, R. D. (2021). A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers, 13(21), 5504. https://doi.org/10.3390/cancers13215504
Authors:
Alexander N Shoushtari
Shaheer Khan
Kimberly Komatsubara
Lynn Feun
Nicolas Acquavella
Shahnaz Singh-Kandah
Tiffany Negri
Alexandra Nesson
Kelly Abbate
Serge Cremers
Elgilda Musi
Grazia Ambrosini
Shing Lee
Gary K Schwartz
Richard D Carvajal
Affiliated Authors:
Shaheer Khan
Kimberly Komatsubara
Shahnaz Singh-Kandah
Tiffany Negri
Alexandra Nesson
Serge Cremers
Elgilda Musi
Grazia Ambrosini
Shing Lee
Gary K Schwartz
Richard D Carvajal
Columbia Affiliation:
Subjects:
Ocular Cancer Research and Treatment (OpenAlex Topic)
Immunobiology of Dendritic Cells (OpenAlex Topic)
Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)
Author Keywords:
uveal melanoma
targeted therapy
sotrastaurin
alpelisib
pkc
pi3k
elink
Publication Type:
Article
Unique ID:
10.3390/cancers13215504
PMID:
34771668
DOI:
10.3390/cancers13215504
Journal:
Cancers
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View OpenAlex Record
View Web of Science Record

Record Created: